Validated LC-MS-MS method for the determination of gabapentin in human plasma: Application to a bioequivalence study

Journal of Chromatographic Science

Volumn 47, Issue 10, 2009, Pages 868-871

  Wattananat, Triporn ^a   Akarawut, Wiyada ^a  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70450177130     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/47.10.868     Document Type: Article

References (23)

1. Physicians' Desk Reference; 59th ed. Thomson PDR, Montvale, NJ, 2005, pp. 2589-93.
2. Z. Zhu and L. Neirinck. High-performance liquid chromatographic method for the determination of gabapentin in human plasma. J. Chromatogr. B 779: 307-312 (2002).
3. O. Sagirli, S.M. Cetin, and A. Onal. Determination of gabapentin in human plasma and urine by high-performance liquid chromatography with UV-vis detection. J. Pharm. Biomed. Anal. 42: 618-624 (2006).
4. H. Jalalizadeh, E. Souri, M.B. Tehrani, and A. Jahangiri. Validated HPLC method for the determination of gabapentin in human plasma using pre-column derivatization with 1-fluoro-2,4-dinitrobenzene and its application to a pharmacokinetic study. J. Chromatogr. B 854: 43-47 (2007).
5. G. Forrest, G.J. Sills, J.P. Leach, and M.J. Brodie. Determination of gabapentin in plasma by high-performance liquid chromatography. J. Chromatogr. B 681: 421-425 (1996).
6. P.H. Tang, M.V. Miles, T.A. Glauser, and T. Degrauw. Automated microanalysis of gabapentin in human serum by high-performance liquid chromatography with fluorometric detection. J. Chromatogr. B 727: 125-129 (1999).
7. E.M. Hassan, F. Belal, O.A. Al-Deeb, and N.Y. Khalil. Spectrofluorimetric determination of vigabatrin and gabapentin in dosage forms and spiked plasma samples through derivatization with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole. J. AOAC Int. 84: 1017-1024 (2001).
8. D. Gauthier and R. Gupta. Determination of gab apentin in plasma by liquid chromatography with fluorescence detection after solid-phase extraction with a C18 column. Clin. Chem. 48: 2259-2261 (2002).
9. T.C. Chung, C.T. Tai, and H.L. Wu. Simple and sensitive liquid chromatographic method with fluorimetric detection for the analysis of gabapentin in human plasma. J. Chromatogr. A 1119: 294-298 (2006).
10. G. Bahrami and A. Kiani. Sensitive high-performance liquid chromatographic quantitation of gabapentin in human serum using liquid-liquid extraction and pre-column derivatization with 9-fluorenylmethyl chloroformate. J. Chromatogr. B 835: 123-126 (2006).
11. P. Krivanek, K. Koppatz, and K. Turnheim. Simultaneous isocratic HPLC determination of vigabatrin and gabapentin in human plasma by dansyl derivatization. Ther. Drug Monit. 25: 374-377 (2003).
12. S.Y. Chang and F.Y. Wang. Simple and sensitive liquid chromatographic method with fluorimetric detection for the analysis of gabapentin in human plasma. J. Chromatogr. B 799: 265-270 (2004).
13. C.E. Wolf, J.J. Saady, and A. Poklis. Determination of gabapentin in serum using solid-phase extraction and gas-liquid chromatography. J. Anal. Toxicol. 20: 498-501 (1996).
14. M.M. Kushnir, J. Cossett, P.I. Brown, and F.M. Urry. Analysis of gabapentin in serumand plasma by solid-phase extraction and gas chromatography-mass spectrometry for therapeutic drug monitoring. J. Anal. Toxicol. 23: 1-6 (1999).
15. D.C. Borrey, K.O. Godderis, V.I. Engelrelst, D.R. Bernard, and M.R. Langlois. Quantitative determination of vigabatrin and gabapentin in human serum by gas chromatography-mass spectrometry. Clin. Chim. Acta 354: 147-151 (2005).
16. C. Gambelunghe, G. Mariucci, M. Tantucci, and M.V. Ambrosini. Gas chromatography-tandemmassspectrometryanalysisof gabapentininserum. Biomed. Chromatogr. 19: 63-67 (2005).
17. K.M. Matar and M.E. Abdel-Hamid. Rapid tandem mass spectrometric method for determination of gabapentin in human plasma. Chromatographia 61: 499-504 (2005).
18. N.V.S. Ramakrishna, K.N. Vishwottam, M. Koteshwara, S. Maroj, S.M. Santosh, J. Chidambara, B. Sumatha, and D.P. Varma. Rapid quantification of gabapentin in human plasma by liquid chromatography/ tandem mass spectrometry. J.Pharm. Biomed. Anal. 40: 360-368 (2006).
19. D.R. Ifa, M. Falci, M.E. Moraes, F.A. Bezerra, M.O. Moraes, and G. de Nucci. Gabapentin quantification in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry. Application to bioequivalence study. J. Mass Spectrom. 36: 188-194 (2001).
20. H.Y. Ji, D.W. Jeong, Y.H. Kim, H.H. Kim, Y.S. Yoon, K.C. Lee, and H.S. Lee. Determination of gabapentin in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry. Rapid Commun. Mass Spectrom. 20: 2127-2132 (2006).
21. K.C. Carlsson and J.L Reubsaet. Sample preparation and determination of gabapentin in venous and capillary blood using liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 34: 415-423 (2004).
22. J.H. Park, O.H. Jhee, S.H. Park, J.S. Lee, M.H. Lee, L.M. Shaw, K.H. Kim, J.H. Lee, Y.S. Kim, and J.S. Kang. Validated LC-MS/MS method for quantification of gabapentin in human plasma: application to pharmacokinetic and bioequivalence studies in Korean volunteers. Biomed. Chromatogr. 21: 829-835 (2007).
23. Guidance for Industry, Bioanalytical Method Validation, US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), 2001.